Search
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 901 - 915 of 1082 items.
Centre for Probe Development and Commercialization Products Recall (2019-04-17)
RecallHealth product recall | 2019-04-17
Unauthorized products may pose serious health risks (December 10, 2018 to April 17, 2019)
AlertPublic advisory | 2019-04-17
Intragastric Balloons and Potential Risk of Gastric and Esophageal Perforation, Pancreatitis, and Overinflation
AlertHealth professional risk communication | 2019-04-17
Auro-Irbesartan HCT Tablet (2019-04-17)
RecallHealth product recall | 2019-04-17
Ibuprofen tablets (2019-04-16)
RecallHealth product recall | 2019-04-16
Multiple unauthorized eye solutions and an acne gel sold at two stores in the Lower Mainland of BC may pose serious health risks
AlertPublic advisory | 2019-04-15
Health Canada testing identifies additional health risks involving unauthorized products sold by A1 Herbal Ayurvedic Clinic Ltd.
AlertInformation update | 2019-04-12
Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
RecallHealth product recall | 2019-04-12
PMS-Sulfasalazine product recall (2019-04-09)
RecallHealth product recall | 2019-04-09
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
AlertInformation update | 2019-04-04
Phenobarb Elixir (2019-03-29)
RecallHealth product recall | 2019-03-29
Neutrarinse 2.0% Caramel (2019-03-26)
RecallHealth product recall | 2019-03-26
Thallous Chloride TI 201 Injection (2019-03-26)
RecallHealth product recall | 2019-03-26
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25